Pfizer claims vaccine rollout is set to be almost doubled in coming weeks

Tuesday, February 9
Ciarán Mather

One of the pharmaceutical giants that are developing a COVID-19 vaccine (alongside BioNTech), Pfizer, have announced that production of their vaccines will be sped up by nearly 50 per cent.

The company's first batch initially took 110 days to make, but now it claims that it will only take them 60 days after reassessing and changing their means of production and distribution.

Chaz Calitri, Pfizer's vice president for operations for sterile injectables, who runs the company's plant in Kalamazoo, Michigan, told USA Today News: 'We call this 'Project Light Speed,' and it's called that for a reason.' 

'Just in the last month, we've doubled output.'

Pfizer's vaccine is made at three separate plants: the process starts in Chesterfield, Missouri, then in Andover, Massachusetts, and lastly, in Kalamazoo, Michigan. 

Pfizer has been having a good week so far: in addition to the increase in production and distribution, a recent study has suggested that its vaccine is effective against South African variant.

In related COVID-19 vaccine news, experts have called on people to avoid painkillers before and after receiving the COVID-19 vaccine; just one week after another set of experts claimed that pain relief such as Tylenol and Advil are 'perfectly fine' to take after receiving the vaccine.

Pfizer employs around 5,000 people across five different sites in Ireland, and has invested $8 billion in operations in Ireland since opening the first site in 1969.

Given that Pfizer has a production goal of 2 billion COVID-19 vaccine doses this year, this huge boost in efficiency will likely increase their chances to meet this target.